Document is current
Any future updates will be listed below
-
Authors
Formaggio, Nicolò
Rubin, Mark A. https://orcid.org/0000-0002-8321-9950
Theurillat, Jean-Philippe https://orcid.org/0000-0003-0111-5937
- License Information
-
More Information
Article History
Received: 16 September 2020
Revised: 20 November 2020
Accepted: 30 November 2020
First Online: 8 January 2021
Compliance with ethical standards
:
: MAR is listed as a co-inventor on US and international patents in the diagnostic and therapeutic fields of ETS gene fusion prostate cancers (Harvard and University of Michigan) and separate patents for SPOP/AURKA/NMYC (Weill Cornell Medicine) and has received funding from Sanofi–Aventi, Millennium Pharma, Eli-Lilly, Novartis, Roche, and Janssen. JPT is supported by Swiss National Science Foundation Professorship (310030_197810 and PP00P3_179072) grant, and received funding from Astellas, MSD, Janssen/Cilag, the Swiss Cancer League, the San Salvatore, the Fidinam, and the Nelia and Amadeo Barletta Foundation.
